Search research articles
Contact Us
Filters
Showing results (101-110 of 111) with videos related to
Page
of 12
Sort By:
Cancer Research
|
February 2, 1999
A novel synthetic oleanane triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, with potent differentiating, antiproliferative, and anti-inflammatory activity
N Suh, Y Wang, T Honda, et al.
Blood
|
November 23, 2020
Single-cell RNA-seq reveals developmental plasticity with coexisting oncogenic states and immune evasion programs in ETP-ALL
Praveen Anand, Amy Guillaumet-Adkins, Valeriya Dimitrova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 6, 2021
Efficacy and Toxicity of Pegaspargase and Calaspargase Pegol in Childhood Acute Lymphoblastic Leukemia: Results of DFCI 11-001
Lynda M Vrooman, Traci M Blonquist, Kristen E Stevenson, et al.
Pediatric Blood & Cancer
|
February 12, 2025
Vincristine Sulfate Liposome Injection With Combination Chemotherapy for Children, Adolescents, and Young Adults With Relapsed Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium Trial
Nirali N Shah, Eric S Schafer, Yueh-Yun Chi, et al.
Leukemia
|
May 6, 2018
Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study
Weili Sun, Jemily Malvar, Richard Sposto, et al.
The Lancet. Oncology
|
November 10, 2015
Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial
Andrew E Place, Kristen E Stevenson, Lynda M Vrooman, et al.
Pediatric Blood & Cancer
|
October 7, 2020
Identification of prognostic factors in childhood T-cell acute lymphoblastic leukemia: Results from DFCI ALL Consortium Protocols 05-001 and 11-001
Melissa A Burns, Andrew E Place, Kristen E Stevenson, et al.
Pediatric Blood & Cancer
|
April 23, 2025
Venetoclax Alone or in Combination With Chemotherapy in Paediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Myeloid Leukaemia
Seth E Karol, Seong L Khaw, C Michel Zwaan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2023
Integration of Genomic Sequencing Drives Therapeutic Targeting of PDGFRA in T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
Jonathan Paolino, Boris Dimitrov, Beth Apsel Winger, et al.
Cancer Discovery
|
February 10, 2021
Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory, or High-Risk Leukemias: A Report from the LEAP Consortium
Yana Pikman, Sarah K Tasian, Maria Luisa Sulis, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 111) with videos related to
Sort By:
Page
of 12
Cancer Research
|
February 2, 1999
A novel synthetic oleanane triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, with potent differentiating, antiproliferative, and anti-inflammatory activity
N Suh, Y Wang, T Honda, et al.
Blood
|
November 23, 2020
Single-cell RNA-seq reveals developmental plasticity with coexisting oncogenic states and immune evasion programs in ETP-ALL
Praveen Anand, Amy Guillaumet-Adkins, Valeriya Dimitrova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 6, 2021
Efficacy and Toxicity of Pegaspargase and Calaspargase Pegol in Childhood Acute Lymphoblastic Leukemia: Results of DFCI 11-001
Lynda M Vrooman, Traci M Blonquist, Kristen E Stevenson, et al.
Pediatric Blood & Cancer
|
February 12, 2025
Vincristine Sulfate Liposome Injection With Combination Chemotherapy for Children, Adolescents, and Young Adults With Relapsed Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium Trial
Nirali N Shah, Eric S Schafer, Yueh-Yun Chi, et al.
Leukemia
|
May 6, 2018
Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study
Weili Sun, Jemily Malvar, Richard Sposto, et al.
The Lancet. Oncology
|
November 10, 2015
Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial
Andrew E Place, Kristen E Stevenson, Lynda M Vrooman, et al.
Pediatric Blood & Cancer
|
October 7, 2020
Identification of prognostic factors in childhood T-cell acute lymphoblastic leukemia: Results from DFCI ALL Consortium Protocols 05-001 and 11-001
Melissa A Burns, Andrew E Place, Kristen E Stevenson, et al.
Pediatric Blood & Cancer
|
April 23, 2025
Venetoclax Alone or in Combination With Chemotherapy in Paediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Myeloid Leukaemia
Seth E Karol, Seong L Khaw, C Michel Zwaan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2023
Integration of Genomic Sequencing Drives Therapeutic Targeting of PDGFRA in T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
Jonathan Paolino, Boris Dimitrov, Beth Apsel Winger, et al.
Cancer Discovery
|
February 10, 2021
Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory, or High-Risk Leukemias: A Report from the LEAP Consortium
Yana Pikman, Sarah K Tasian, Maria Luisa Sulis, et al.
Page
of 12